A new pill from Merck could change how millions of people treat high cholesterol and help prevent heart attacks and strokes without the need for injections. The drug, called enlicitide, slashes levels ...

A new pill from Merck could change how millions of people treat high cholesterol and help prevent heart attacks and strokes without the need for injections. The drug, called enlicitide, slashes levels ...

Imagine a future where high cholesterol, a primary driver of heart disease, could be treated with a single injection rather than a lifetime of daily pills. That future may be closer than we think, ...

Merck & Co. Inc. (NYSE:MRK) on Tuesday shared topline results from the Phase 3 CORALreef Lipids trial evaluating the safety and efficacy of enlicitide decanoate for hypercholesterolemia on a moderate ...

Among people with a previous heart attack or stroke, or who are at high risk for one, a daily oral medication may offer an effective alternative to injections of PCSK9 inhibitors to lower low-density ...

Cholesterol management is a critical component of long-term health, and understanding it becomes even more essential as you enter your 30s and beyond. While cholesterol levels may not have been on ...

Two days of intensive oatmeal intake lowered LDL cholesterol and shifted gut bacteria, pointing to a rapid nutrition strategy for lipid control.

Unfortunately you've used all of your gifts this month. Your counter will reset on the first day of next month.

Merck’s new pill, enlicitide, lowered LDL cholesterol by up to 60% in a new trial The pill works just as well as traditional PCSK9 injections but could cost less Researchers hope to receive federal ...

THURSDAY, Nov. 13, 2025 (HealthDay News) — A new pill from Merck could change how millions of people treat high cholesterol and help prevent heart attacks and strokes without the need for injections.